Highlight• A new review examines how anxiety may affect the health and care of patients with kidney failure who are undergoing hemodialysis.

Newswise — Washington, DC (September 22, 2016) — A new review looks at the potential effects of anxiety on a vulnerable patient population: individuals undergoing hemodialysis for the treatment of kidney failure. The review, which appears in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN), stresses that anxiety disorders may interfere with optimal dialysis treatment and lead to additional serious health consequences.

Paul Kimmel, MD (George Washington University and the National Institute of Diabetes and Digestive and Kidney Diseases) and his colleagues present 3 clinical vignettes that highlight the role of anxiety in kidney failure patients treated with dialysis. The vignettes—composites of patients that are used for illustrative purposes and to protect patient privacy—show how anxiety can interfere with patients’ well-being and productivity, as well as their ability to make decisions and participate in self-care. Anxiety disorders can manifest at any time, in various ways, and along with other psychiatric disorders such as depression. Unfortunately, few studies have evaluated lifestyle modification, cognitive-behavioral therapy, and medical treatment of anxiety disorders in dialysis patients.

“Anxiety is an important clinical problem that is underrecognized and understudied in hemodialysis patients,” said Dr. Kimmel. “Anxiety may explain some behaviors that increase health risks, such as when patients demand to use a specific dialysis machine or to stop a dialysis treatment early, or they want to receive treatment only from a particular technician.”

Dr. Kimmel stressed that it is essential to evaluate dialysis patients for anxiety disorders and to go beyond simply asking patients about their moods or anxiety. For many people on dialysis, feeling anxious is their ‘normal’ state, and they may not readily identify it as a problem for which they can and should get help.

Study co-authors include Scott Cohen, MD, MPH, (George Washington University School of Medicine & Health Sciences) and Daniel Cukor, PhD (SUNY Downstate Medical Center).

Disclosures: The authors reported no financial disclosures.

The article, entitled “Anxiety in Patients Treated with Hemodialysis,” will appear online at http://cjasn.asnjournals.org/ on September 22, 2016, doi: 10.2215/CJN.02590316.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has nearly 16,000 members representing 112 countries. For more information, please visit www.asn-online.org or contact us at 202-640-4660. # # #

Register for reporter access to contact details

doi: 10.2215/CJN.02590316